These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32754886)

  • 41. Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak: COVID-19-adapted Recommendations of the National Cancer Institute of Milan.
    Pietrantonio F; Morano F; Niger M; Corallo S; Antista M; Raimondi A; Prisciandaro M; Pagani F; Prinzi N; Nichetti F; Randon G; Torchio M; Corti F; Ambrosini M; Palermo F; Palazzo M; Biamonte L; Platania M; Sposito C; Cosimelli M; Mazzaferro V; Pusceddu S; Cremolini C; de Braud F; Di Bartolomeo M
    Clin Colorectal Cancer; 2020 Sep; 19(3):156-164. PubMed ID: 32513593
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thyroid cancer and COVID-19: experience at one single thyroid disease referral center.
    Prete A; Falcone M; Bottici V; Giani C; Tiseo G; Agate L; Matrone A; Cappagli V; Valerio L; Lorusso L; Minaldi E; Molinaro E; Elisei R
    Endocrine; 2021 May; 72(2):332-339. PubMed ID: 33638758
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of the COVID-19 pandemic on surgery for thyroid cancer in Italy: nationwide retrospective study.
    Medas F; Ansaldo GL; Avenia N; Basili G; Bononi M; Bove A; Carcoforo P; Casaril A; Cavallaro G; Conzo G; De Pasquale L; Del Rio P; Dionigi G; Dobrinja C; Docimo G; Graceffa G; Iacobone M; Innaro N; Lombardi CP; Novelli G; Palestini N; Pedicini F; Perigli G; Pezzolla A; Pezzullo L; Scerrino G; Spiezia S; Testini M; Calò PG;
    Br J Surg; 2021 Apr; 108(4):e166-e167. PubMed ID: 33659983
    [No Abstract]   [Full Text] [Related]  

  • 44. Updated clinical management guidance during the COVID-19 pandemic: thyroid nodules and cancer.
    Giannoula E; Iakovou I; Giovanella L; Vrachimis A
    Eur J Endocrinol; 2022 Feb; 186(4):G1-G7. PubMed ID: 35073277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statement.
    Lenihan D; Carver J; Porter C; Liu JE; Dent S; Thavendiranathan P; Mitchell JD; Nohria A; Fradley MG; Pusic I; Stockerl-Goldstein K; Blaes A; Lyon AR; Ganatra S; López-Fernández T; O'Quinn R; Minotti G; Szmit S; Cardinale D; Alvarez-Cardona J; Curigliano G; Neilan TG; Herrmann J
    CA Cancer J Clin; 2020 Nov; 70(6):480-504. PubMed ID: 32910493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The legacy of the COVID-19 pandemics for thyroid cancer patients: towards the application of clinical practice recommendations.
    Grani G; Ciotti L; Del Gatto V; Montesano T; Biffoni M; Giacomelli L; Sponziello M; Pecce V; Verrienti A; Filetti S; Durante C
    Endocrine; 2023 Jan; 79(1):45-48. PubMed ID: 35857273
    [No Abstract]   [Full Text] [Related]  

  • 47. Endocrine and metabolic aspects of the COVID-19 pandemic.
    Marazuela M; Giustina A; Puig-Domingo M
    Rev Endocr Metab Disord; 2020 Dec; 21(4):495-507. PubMed ID: 32643004
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development.
    Qu N; Hui Z; Shen Z; Kan C; Hou N; Sun X; Han F
    Front Endocrinol (Lausanne); 2022; 13():873027. PubMed ID: 35600591
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of COVID-19 pandemic on diagnosis and treatment of thyroid cancer in Brazil.
    Silveira VB; Schwengber WK; Hetzel GM; Zanella AB; Scheffel RS; Maia AL; Dora JM
    Front Endocrinol (Lausanne); 2022; 13():995329. PubMed ID: 36277724
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of COVID-19 on the management of patients with thoracic cancers in a tertiary referral center.
    Basse C; Daniel C; Livartowski A; Beaucaire-Danel S; Girard N
    Lung Cancer; 2021 Jul; 157():79-84. PubMed ID: 33994016
    [TBL] [Abstract][Full Text] [Related]  

  • 51. COVID-19 in cancer patients.
    Seneviratne SL; Wijerathne W; Yasawardene P; Somawardana B
    Trans R Soc Trop Med Hyg; 2022 Sep; 116(9):767-797. PubMed ID: 35276734
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thyroid cancer clinicians' views and experiences of delayed treatment during the COVID-19 pandemic: An international cross-sectional survey.
    Nickel B; Miller JA; Cvejic E; Gild ML; Cope D; Dodd R; McCaffery K; Glover A
    ANZ J Surg; 2021 Dec; 91(12):2562-2564. PubMed ID: 34350698
    [No Abstract]   [Full Text] [Related]  

  • 53. Use of systemic therapies for psoriasis in the COVID-19 era.
    Kearns DG; Uppal S; Chat VS; Wu JJ
    J Dermatolog Treat; 2022 Mar; 33(2):622-625. PubMed ID: 32459567
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Managing Lung Cancer during Coronavirus Disease 2019 Pandemic.
    Khalifeh YI; Tfayli AH
    Turk Thorac J; 2021 Mar; 22(2):163-168. PubMed ID: 33871341
    [TBL] [Abstract][Full Text] [Related]  

  • 55. COVID-19 in patients with hematological malignancies: Considering the role of tyrosine kinase inhibitors.
    Morales-Ortega A; García de Tena J; Frutos-Pérez B; Jaenes-Barrios B; Farfán-Sedano AI; Canales-Albendea MÁ; Bernal-Bello D
    Cancer; 2021 Jun; 127(11):1937-1938. PubMed ID: 33721325
    [No Abstract]   [Full Text] [Related]  

  • 56. The COVID-19 outbreak and de-escalation of thyroid cancer diagnosis and treatment.
    Grani G; Ciotti L; Del Gatto V; Montesano T; Biffoni M; Giacomelli L; Sponziello M; Pecce V; Lucia P; Verrienti A; Filetti S; Durante C
    Endocrine; 2022 Nov; 78(2):387-391. PubMed ID: 35802229
    [No Abstract]   [Full Text] [Related]  

  • 57. Emerging Developments in Management of Melanoma During the COVID-19 Era.
    Li AR; Valdebran M; Reuben DY
    Front Med (Lausanne); 2021; 8():769368. PubMed ID: 34820401
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Charting the Unknown Association of COVID-19 with Thyroid Cancer, Focusing on Differentiated Thyroid Cancer: A Call for Caution.
    Deligiorgi MV; Siasos G; Vakkas L; Trafalis DT
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thyroid substitution may be a risk factor for Covid-19.
    Bacle A; Malledant Y; Mercerolle M; Pronier C; Nesseler N; Barbazan C; Garlantezec R
    Endocrine; 2021 Sep; 73(3):507-508. PubMed ID: 34212315
    [No Abstract]   [Full Text] [Related]  

  • 60. Reply: The clinical outcome of COVID-19 infection in patients with a history of thyroid cancer: A nationwide study.
    Abobaker A; Darrat M
    Clin Endocrinol (Oxf); 2023 Mar; 98(3):447-448. PubMed ID: 34951050
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.